Bombesin-like immunoreactivity in human gastrointestinal tract.
In the present study the distribution and molecular characteristics of bombesin-like immunoreactivity (BLI) were studied in acid extracts of human gastrointestinal tract. The highest levels were found in the fundus, antrum, pylorus and pancreas with lower levels in the duodenum, jejunum, terminal ileum and colon. BLI was also detected in both the muscle and mucosal layers of the antrum and colon. Sephadex G-50 gel chromatography under acid dissociating conditions revealed two peaks of immunoreactivity, one in the position of synthetic porcine gastrin releasing peptide (GRP) and the second eluting with synthetic amphibian bombesin. Variations in the proportions of the two molecular forms were seen in different regions of the gut. In the stomach and pancreas greater than 70% of the BLI eluted with the GRP marker while in pylorus, jejunum and terminal ileum only 20% was present in this form. Reverse-phase ODS silica HPLC of the major antral BLI peak, utilising a methanol/trifluoroacetic acid gradient indicated that this peptide was similar to porcine GRP. We have therefore (1) demonstrated the presence and heterogeneity of bombesin-like immunoreactivity throughout the human gastrointestinal tract and (2) shown for the first time that a proportion of this BLI closely resembles porcine GRP.
D000818:Animals; D001839:Bombesin / Q000276:immunology / Q000302:isolation & purification / Q000378:metabolism*; D004064:Digestive System / Q000378:metabolism*; D019886:Gastrin-Releasing Peptide; D006801:Humans; D010455:Peptides / Q000302:isolation & purification / Q000378:metabolism*; D011863:Radioimmunoassay; D013552:Swine; D014018:Tissue Distribution
D010455:Peptides; D019886:Gastrin-Releasing Peptide; D001839:Bombesin